MYASTHENIA GRAVIS
Clinical trials for MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major drug trial for Muscle-Weakening disease halted after just 6 patients
Disease control TerminatedThis study aimed to test whether an oral drug called tolebrutinib could help control symptoms and improve daily life for adults with moderate-to-severe generalized myasthenia gravis (gMG), a chronic autoimmune disease that causes muscle weakness. It was a large Phase 3 trial desi…
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Trial halted early: could a common nausea drug help MG patients tolerate treatment?
Symptom relief TerminatedThis study aimed to see if adding the anti-nausea drug ondansetron could help people with myasthenia gravis better tolerate the stomach side effects (like nausea and diarrhea) of pyridostigmine, a standard medication. It was a small, short-term trial for adults who either had tro…
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE2 • Sponsor: DAS-MG, Inc • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC